首頁 > 市場調查報告書 > 醫療設備

體外診斷人工智能診斷用人工智能

市場調查報告書

商品編碼

1756477

人工智慧診斷市場（按組件、按診斷、按國家和地區）—2024 年至 2032 年的行業分析、市場規模、市場佔有率和預測

Artificial Intelligence in Diagnostics Market, By Component, By Diagnosis, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

出版日期: 2025年05月23日 | 出版商:

AnalystView Market Insights | 英文 398 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

報告重點

2024 年診斷人工智慧市場規模價值 15.6712 億美元，2024 年至 2032 年的複合年成長率為 22.5%。

診斷市場中的人工智慧-市場動態

對早期和準確疾病檢測的需求不斷成長

對早期精準診斷的日益重視是人工智慧診斷市場發展的主要驅動力。全球醫療保健系統都高度重視及時發現疾病，以改善患者預後並降低治療成本。人工智慧透過快速分析醫學影像、基因圖譜和電子健康記錄等複雜資料集，提升診斷準確性。這種能力有助於早期發現癌症、心血管疾病和神經系統疾病等疾病。因此，醫院、診所和診斷實驗室擴大採用人工智慧工具，以最大限度地減少錯誤，加快診斷速度，並支持個人化治療決策。

診斷市場中的人工智慧—關鍵見解

根據我們的研究分析師，全球診斷人工智慧市場預計在 2024 年至 2032 年期間的複合年成長率約為 22.5%。

2024 年按組件細分，軟體類別佔據了市場主導地位。

根據診斷，放射科部門在 2024 年創造了最多的收入。

按地區分類，2024年北美是收入最高的地區。

診斷市場中的人工智慧-細分分析：

全球診斷人工智慧市場分為三類：組件、診斷和區域。

診斷人工智慧市場按組件細分為軟體、硬體和服務。其中，軟體因其在處理資料、執行演算法和產生診斷輸出方面的核心作用而成為主導部分。人工智慧軟體解決方案對於解讀醫學影像、分析實驗室結果和支援臨床決策至關重要。這些平台透過機器學習不斷發展，隨著時間的推移提高準確性並適應複雜的診斷挑戰。人工智慧軟體與醫院系統、電子健康記錄 (EHR) 和影像設備的日益整合進一步鞏固了其市場領導地位。此外，軟體解決方案提供可擴展性、遠端存取和成本效益，與通常需要更高前期投資和基礎設施支援的硬體和服務組件相比，它們對醫療保健提供者更具吸引力。

人工智慧診斷市場按診斷細分為心臟病學、腫瘤學、病理學、放射學、胸肺、神經病學等。其中，放射學佔據主導地位，因為它會產生大量影像資料，並且迫切需要準確的解釋。人工智慧正在透過增強對X光、核磁共振成像、CT掃描和超音波的分析來徹底改變放射學，使其能夠更快、更準確地檢測腫瘤、骨折和內出血等異常情況。人工智慧演算法能夠檢測細微模式並減少診斷錯誤，使其成為放射科醫生的寶貴工具。此外，對影像診斷的需求不斷成長，尤其是在慢性病管理和急救護理方面，這繼續推動人工智慧在放射學中的應用，鞏固其市場領導地位。

診斷市場中的人工智慧—地理洞察

從地理分佈來看，診斷人工智慧市場分佈於北美、亞太、拉丁美洲、歐洲、中東和非洲。這些地區根據業務來源國進一步分類。

北美在診斷人工智慧市場佔據主導地位，主要由美國推動。該地區受益於完善的醫療基礎設施、對人工智慧技術的大量投資以及政府的支持性舉措。領先的科技公司和新創公司與醫院合作開發先進的診斷工具，尤其是在放射科和腫瘤科領域。電子健康記錄 (EHR) 的高採用率、慢性病盛行率的上升以及對精準醫療日益成長的需求進一步推動了市場成長。 FDA 等監管機構積極批准基於人工智慧的診斷工具，增強了人們對臨床應用的信心。這些因素使北美成為人工智慧驅動診斷創新的全球領導者。

亞太地區正成為人工智慧診斷市場的關鍵成長區域，其中以中國、日本和印度等國家為主導。醫療保健領域的快速數位轉型、人工智慧新創公司投資的不斷成長以及政府對醫療科技創新的日益重視，正在推動市場擴張。該地區面臨著患者數量龐大、慢性病發病率不斷上升的局面，對可擴展、高效的診斷解決方案的需求強勁。此外，中國的人工智慧發展計畫和印度推動數位化醫療等措施也強化了該地區的生態系統。當地醫院與全球科技公司之間的合作正在加速人工智慧的普及，使亞太地區成為一個充滿活力且快速擴張的市場。

診斷市場中的人工智慧-競爭格局：

人工智慧診斷市場的競爭態勢由成熟的醫療和醫療科技巨頭以及敏捷的新創公司共同塑造，這些公司推動創新。西門子醫療、通用電氣醫療、Aidoc 和 Digital Diagnostics, Inc. 等公司憑藉專注於醫學影像、心臟病學和病理學的強大人工智慧平台佔據主導地位。這些領導者優先考慮研發投入、法規合規性和策略合作夥伴關係，以擴展其人工智慧產品組合。同時，Vuno, Inc. 和 NovaSignal Corporation 等新興企業帶來了顛覆性的解決方案，尤其是在神經病學和即時資料分析領域。這種良性競爭格局促進了產品的持續改進、人工智慧在診斷領域的更廣泛應用，並增強了對醫療專業人員的臨床決策支援。

介紹
- 按地區分類的細分市場佔有率分析
北美洲
- 概述
- 北美診斷領域人工智慧主要製造商
- 北美市場規模及預測（按國家/地區）
- 北美市場規模及預測（按組件）
- 北美市場規模及預測（按診斷）
- 美國
- 加拿大
歐洲
- 概述
- 歐洲診斷領域人工智慧主要製造商
- 歐洲市場規模及預測（按國家/地區）
- 歐洲市場規模及預測（按組成部分）
- 歐洲市場規模及預測（依診斷）
- 德國
- 法國
- 義大利
- 西班牙
- 英國
- 俄羅斯
- 荷蘭
- 瑞典
- 波蘭
- 歐洲其他地區
亞太地區 (APAC)
- 概述
- 亞太地區診斷領域人工智慧主要製造商
- 亞太市場規模及預測（按國家/地區）
- 亞太市場規模及預測（按組成部分）
- 亞太市場規模及預測（依診斷）
- 印度
- 中國
- 韓國
- 日本
- 澳洲
- 泰國
- 印尼
- 菲律賓
- 亞太地區其他地區
拉丁美洲
- 概述
- 拉丁美洲診斷領域人工智慧主要製造商
- 拉丁美洲市場規模及預測（按國家/地區）
- 拉丁美洲市場規模及預測（按組成部分）
- 拉丁美洲市場規模及預測（按診斷）
- 巴西
- 墨西哥
- 阿根廷
- 哥倫比亞
- 拉丁美洲其他地區
中東和非洲
- 概述
- 中東和非洲診斷領域人工智慧主要製造商
- 中東和非洲市場規模及預測（按國家/地區）
- 中東和非洲市場規模及預測（按組成部分）
- 中東和非洲市場規模及預測（按診斷）
- 沙烏地阿拉伯
- 阿拉伯聯合大公國
- 以色列
- 土耳其
- 阿爾及利亞
- 埃及
- MEA 其餘地區

第10章：關鍵供應商分析-診斷產業人工智慧

競爭儀錶板
公司簡介
- Siemens Healthineers
- Zebra Technologies Corp.
- Riverain Technologies
- Vuno, Inc.
- Aidoc
- NovaSignal Corporation
- Imagen
- Digital Diagnostics, Inc.
- GE Healthcare
- AliveCor Inc.
- F. Hoffmann-La Roche Ltd
- Others

第 11 章：360 度分析師視角

第 12 章：附錄

研究方法
參考
縮寫
免責聲明
聯絡我們

簡介目錄

Product Code: ANV5269

REPORT HIGHLIGHT

Artificial Intelligence in Diagnostics Market size was valued at USD 1,567.12 Million in 2024, expanding at a CAGR of 22.5% from 2024 to 2032.

Artificial Intelligence in Diagnostics refers to the use of advanced algorithms and machine learning techniques to analyze medical data and assist in identifying diseases or conditions. By processing vast amounts of clinical information, imaging, and patient history, AI systems can detect patterns and anomalies often invisible to the human eye. This technology enhances accuracy, speeds up diagnosis, and supports healthcare professionals in making informed decisions. AI-driven diagnostics improve early disease detection, personalize treatment plans, and optimize healthcare outcomes while reducing errors and costs. It represents a transformative tool in modern medicine, integrating data science with clinical expertise.

Artificial Intelligence in Diagnostics Market- Market Dynamics

Rising Demand for Early and Accurate Disease Detection

The growing emphasis on early and precise diagnosis is a major driver for the AI in diagnostics market. Healthcare systems worldwide are prioritizing timely identification of diseases to improve patient outcomes and reduce treatment costs. Artificial Intelligence enhances diagnostic accuracy by swiftly analyzing complex datasets such as medical images, genetic profiles, and electronic health records. This capability supports early detection of conditions like cancer, cardiovascular diseases, and neurological disorders. As a result, hospitals, clinics, and diagnostic labs are increasingly adopting AI tools to minimize errors, accelerate diagnosis, and support personalized treatment decisions.

Artificial Intelligence in Diagnostics Market- Key Insights

According to our research analyst, the global Artificial Intelligence in Diagnostics Market is expected to develop at a CAGR of approximately 22.5% between 2024-2032.

Segmented by Component in 2024, the Software category dominated the market.

Based on Diagnosis, the Radiology segment generated the most income in 2024.

On the basis of region, in 2024, North America was the region with the highest revenue.

Artificial Intelligence in Diagnostics Market- Segmentation Analysis:

The global Artificial Intelligence in Diagnostics Market is divided into Three categories: Component, Diagnosis, and Region.

The Artificial Intelligence in Diagnostics market is segmented by component into software, hardware, and services. Among these, software emerges as the dominant segment due to its central role in processing data, executing algorithms, and generating diagnostic outputs. AI-powered software solutions are integral for interpreting medical images, analyzing lab results, and supporting clinical decision-making. These platforms continuously evolve through machine learning, improving accuracy over time and adapting to complex diagnostic challenges. The growing integration of AI software with hospital systems, electronic health records (EHRs), and imaging equipment further strengthens its market leadership. Additionally, software solutions offer scalability, remote access, and cost-efficiency, making them more attractive to healthcare providers compared to hardware and service components, which often require higher upfront investments and infrastructure support.

The Artificial Intelligence in Diagnostics market, by diagnosis, is segmented into cardiology, oncology, pathology, radiology, chest and lung, neurology, and others. Among these, radiology holds the dominant share due to the vast volume of imaging data it generates and the critical need for accurate interpretation. AI is revolutionizing radiology by enhancing the analysis of X-rays, MRIs, CT scans, and ultrasounds, enabling faster and more accurate detection of abnormalities such as tumors, fractures, and internal bleeding. The ability of AI algorithms to detect subtle patterns and reduce diagnostic errors makes them invaluable tools for radiologists. Furthermore, rising demand for imaging diagnostics, especially in chronic disease management and emergency care, continues to drive AI adoption in radiology, reinforcing its market leadership.

Artificial Intelligence in Diagnostics Market- Geographical Insights

Geographically, the Artificial Intelligence in Diagnostics Market is distributed throughout North America, Asia Pacific, Latin America, Europe, the Middle East, and Africa. These regions are further divided based on the nations bringing in business.

North America dominates the Artificial Intelligence in Diagnostics market, primarily driven by the United States. The region benefits from a well-established healthcare infrastructure, significant investments in AI technologies, and supportive government initiatives. Leading tech firms and startups collaborate with hospitals to develop advanced diagnostic tools, especially in radiology and oncology. High adoption rates of electronic health records (EHRs), rising chronic disease prevalence, and increasing demand for precision medicine further fuel market growth. Regulatory bodies like the FDA actively approve AI-based diagnostic tools, boosting confidence in clinical applications. These factors position North America as a global leader in AI-driven diagnostic innovations.

Asia Pacific is emerging as a key growth region in the AI in Diagnostics market, led by countries such as China, Japan, and India. Rapid digital transformation in healthcare, growing investments in AI startups, and increasing government focus on health tech innovation are propelling market expansion. The region faces high patient volumes and rising incidences of chronic diseases, creating a strong demand for scalable, efficient diagnostic solutions. Additionally, initiatives like China's AI development plans and India's push for digital healthcare strengthen the ecosystem. Collaborations between local hospitals and global tech companies are accelerating AI adoption, making Asia Pacific a dynamic and rapidly expanding market.

Artificial Intelligence in Diagnostics Market- Competitive Landscape:

The competitive dynamics of the Artificial Intelligence in Diagnostics market are shaped by established healthcare and med-tech giants alongside agile startups driving innovation. Companies such as Siemens Healthineers, GE Healthcare, Aidoc, and Digital Diagnostics, Inc. dominate through robust AI platforms focused on medical imaging, cardiology, and pathology. These leaders prioritize R&D investments, regulatory compliance, and strategic partnerships to expand their AI portfolios. Meanwhile, emerging players like Vuno, Inc. and NovaSignal Corporation bring disruptive solutions, particularly in neurology and real-time data analysis. This healthy competitive mix promotes continuous product advancement, broader AI integration in diagnostics, and enhanced clinical decision support for healthcare professionals.

Recent Developments:

In March 2024, Aidoc partnered with the American College of Radiology to launch a nationwide clinical AI deployment initiative, enhancing stroke and pulmonary embolism detection.

In January 2025, Vuno, Inc. received European CE certification for its AI-powered VUNO Med-Chest X-ray(TM) solution, accelerating its expansion across EU healthcare systems.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL ARTIFICIAL INTELLIGENCE IN DIAGNOSTICS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Siemens Healthineers
Zebra Technologies Corp.
Riverain Technologies
Vuno, Inc.
Aidoc
NovaSignal Corporation
Imagen
Digital Diagnostics, Inc.
GE Healthcare
AliveCor Inc.
F. Hoffmann-La Roche Ltd
Others

GLOBAL ARTIFICIAL INTELLIGENCE IN DIAGNOSTICS MARKET, BY COMPONENT - MARKET ANALYSIS, 2019 - 2032

Software
Hardware
Services

GLOBAL ARTIFICIAL INTELLIGENCE IN DIAGNOSTICS MARKET, BY DIAGNOSIS - MARKET ANALYSIS, 2019 - 2032

Cardiology
Oncology
Pathology
Radiology
Chest and Lung
Neurology
Others

GLOBAL ARTIFICIAL INTELLIGENCE IN DIAGNOSTICS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

North America
The U.S.
Canada
Europe
Germany
France
Italy
Spain
United Kingdom
Russia
Netherlands
Sweden
Poland
Rest of Europe
Asia Pacific
India
China
South Korea
Japan
Australia
Thailand
Indonesia
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
United Arab Emirates
Israel
Turkey
Algeria
Egypt
Rest of MEA

1. Artificial Intelligence in Diagnostics Market Overview

1.1. Study Scope
1.2. Market Estimation Years

2. Executive Summary

2.1. Market Snippet
- 2.1.1. Artificial Intelligence in Diagnostics Market Snippet by Component
- 2.1.2. Artificial Intelligence in Diagnostics Market Snippet by Diagnosis
- 2.1.3. Artificial Intelligence in Diagnostics Market Snippet by Country
- 2.1.4. Artificial Intelligence in Diagnostics Market Snippet by Region
2.2. Competitive Insights

3. Artificial Intelligence in Diagnostics Key Market Trends

3.1. Artificial Intelligence in Diagnostics Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
3.2. Artificial Intelligence in Diagnostics Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
3.3. Artificial Intelligence in Diagnostics Market Opportunities
3.4. Artificial Intelligence in Diagnostics Market Future Trends

4. Artificial Intelligence in Diagnostics Industry Study

4.1. PEST Analysis
4.2. Porter's Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis

5. Artificial Intelligence in Diagnostics Market: COVID-19 Impact Analysis

5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
- 5.2.1. Top Performing Segments
- 5.2.2. Marginal Growth Segments
- 5.2.3. Top Looser Segments
- 5.2.4. Marginal Loss Segments

6. Artificial Intelligence in Diagnostics Market Landscape

6.1. Artificial Intelligence in Diagnostics Market Share Analysis, 2023
6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis

7. Artificial Intelligence in Diagnostics Market - By Component

7.1. Overview
- 7.1.1. Segment Share Analysis, By Component, 2023 & 2032 (%)
- 7.1.2. Software
- 7.1.3. Hardware
- 7.1.4. Services

8. Artificial Intelligence in Diagnostics Market - By Diagnosis

8.1. Overview
- 8.1.1. Segment Share Analysis, By Diagnosis, 2023 & 2032 (%)
- 8.1.2. Cardiology
- 8.1.3. Oncology
- 8.1.4. Pathology
- 8.1.5. Radiology
- 8.1.6. Chest and Lung
- 8.1.7. Neurology
- 8.1.8. Others

9. Artificial Intelligence in Diagnostics Market- By Geography

9.1. Introduction
- 9.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
9.2. North America
- 9.2.1. Overview
- 9.2.2. Artificial Intelligence in Diagnostics Key Manufacturers in North America
- 9.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 9.2.4. North America Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
- 9.2.5. North America Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
- 9.2.6. U.S.
  - 9.2.6.1. Overview
  - 9.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.2.6.3. U.S. Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  - 9.2.6.4. U.S. Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
- 9.2.7. Canada
  - 9.2.7.1. Overview
  - 9.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.2.7.3. Canada Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  - 9.2.7.4. Canada Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
9.3. Europe
- 9.3.1. Overview
- 9.3.2. Artificial Intelligence in Diagnostics Key Manufacturers in Europe
- 9.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 9.3.4. Europe Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
- 9.3.5. Europe Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
- 9.3.6. Germany
  - 9.3.6.1. Overview
  - 9.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.3.6.3. Germany Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  - 9.3.6.4. Germany Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
- 9.3.7. France
  - 9.3.7.1. Overview
  - 9.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.3.7.3. France Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  - 9.3.7.4. France Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
- 9.3.8. Italy
  - 9.3.8.1. Overview
  - 9.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.3.8.3. Italy Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  - 9.3.8.4. Italy Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
- 9.3.9. Spain
  - 9.3.9.1. Overview
  - 9.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.3.9.3. United Kingdom Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  - 9.3.9.4. United Kingdom Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
- 9.3.10. United Kingdom
  - 9.3.10.1. Overview
  - 9.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.3.10.3. United Kingdom Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  - 9.3.10.4. United Kingdom Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
- 9.3.11. Russia
  - 9.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.3.11.2. Russia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  - 9.3.11.3. Russia Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
- 9.3.12. Netherlands
  - 9.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.3.12.2. Netherlands Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  - 9.3.12.3. Netherlands Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
- 9.3.13. Sweden
  - 9.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.3.13.2. Sweden Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  - 9.3.13.3. Sweden Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
- 9.3.14. Poland
  - 9.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.3.14.2. Poland Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  - 9.3.14.3. Poland Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
- 9.3.15. Rest of Europe
  - 9.3.15.1. Overview
  - 9.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.3.15.3. Rest of the Europe Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  - 9.3.15.4. Rest of the Europe Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
9.4. Asia Pacific (APAC)
- 9.4.1. Overview
- 9.4.2. Artificial Intelligence in Diagnostics Key Manufacturers in Asia Pacific
- 9.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 9.4.4. Asia Pacific Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
- 9.4.5. Asia Pacific Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
- 9.4.6. India
  - 9.4.6.1. Overview
  - 9.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.4.6.3. India Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  - 9.4.6.4. India Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
- 9.4.7. China
  - 9.4.7.1. Overview
  - 9.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.4.7.3. China Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  - 9.4.7.4. China Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
- 9.4.8. South Korea
  - 9.4.8.1. Overview
  - 9.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.4.8.3. South Korea Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  - 9.4.8.4. South Korea Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
- 9.4.9. Japan
  - 9.4.9.1. Overview
  - 9.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.4.9.3. Japan Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  - 9.4.9.4. Japan Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
- 9.4.10. Australia
  - 9.4.10.1. Overview
  - 9.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.4.10.3. Australia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  - 9.4.10.4. Australia Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
- 9.4.11. Thailand
  - 9.4.11.1. Overview
  - 9.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.4.11.3. Thailand Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  - 9.4.11.4. Thailand Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
- 9.4.12. Indonesia
  - 9.4.12.1. Overview
  - 9.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.4.12.3. Indonesia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  - 9.4.12.4. Indonesia Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
- 9.4.13. Philippines
  - 9.4.13.1. Overview
  - 9.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.4.13.3. Philippines Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  - 9.4.13.4. Philippines Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
- 9.4.14. Rest of APAC
  - 9.4.14.1. Overview
  - 9.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.4.14.3. Rest of APAC Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  - 9.4.14.4. Rest of APAC Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
9.5. Latin America
- 9.5.1. Overview
- 9.5.2. Artificial Intelligence in Diagnostics Key Manufacturers in Latin America
- 9.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 9.5.4. Latin America Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
- 9.5.5. Latin America Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
- 9.5.6. Brazil
  - 9.5.6.1. Overview
  - 9.5.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.5.6.3. Brazil Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  - 9.5.6.4. Brazil Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
- 9.5.7. Mexico
  - 9.5.7.1. Overview
  - 9.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.5.7.3. Mexico Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  - 9.5.7.4. Mexico Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
- 9.5.8. Argentina
  - 9.5.8.1. Overview
  - 9.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.5.8.3. Argentina Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  - 9.5.8.4. Argentina Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
- 9.5.9. Colombia
  - 9.5.9.1. Overview
  - 9.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.5.9.3. Colombia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  - 9.5.9.4. Colombia Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
- 9.5.10. Rest of LATAM
  - 9.5.10.1. Overview
  - 9.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.5.10.3. Rest of LATAM Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  - 9.5.10.4. Rest of LATAM Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
9.6. Middle East and Africa
- 9.6.1. Overview
- 9.6.2. Artificial Intelligence in Diagnostics Key Manufacturers in Middle East and Africa
- 9.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 9.6.4. Middle East and Africa Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
- 9.6.5. Middle East and Africa Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
- 9.6.6. Saudi Arabia
  - 9.6.6.1. Overview
  - 9.6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.6.6.3. Saudi Arabia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  - 9.6.6.4. Saudi Arabia Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
- 9.6.7. United Arab Emirates
  - 9.6.7.1. Overview
  - 9.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.6.7.3. United Arab Emirates Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  - 9.6.7.4. United Arab Emirates Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
- 9.6.8. Israel
  - 9.6.8.1. Overview
  - 9.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.6.8.3. Israel Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  - 9.6.8.4. Israel Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
- 9.6.9. Turkey
  - 9.6.9.1. Overview
  - 9.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.6.9.3. Turkey Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  - 9.6.9.4. Turkey Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
- 9.6.10. Algeria
  - 9.6.10.1. Overview
  - 9.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.6.10.3. Algeria Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  - 9.6.10.4. Algeria Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
- 9.6.11. Egypt
  - 9.6.11.1. Overview
  - 9.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.6.11.3. Egypt Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  - 9.6.11.4. Egypt Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
- 9.6.12. Rest of MEA
  - 9.6.12.1. Overview
  - 9.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.6.12.3. Rest of MEA Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  - 9.6.12.4. Rest of MEA Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)

10. Key Vendor Analysis- Artificial Intelligence in Diagnostics Industry

10.1. Competitive Dashboard
10.2. Company Profiles
- 10.2.1. Siemens Healthineers
- 10.2.2. Zebra Technologies Corp.
- 10.2.3. Riverain Technologies
- 10.2.4. Vuno, Inc.
- 10.2.5. Aidoc
- 10.2.6. NovaSignal Corporation
- 10.2.7. Imagen
- 10.2.8. Digital Diagnostics, Inc.
- 10.2.9. GE Healthcare
- 10.2.10. AliveCor Inc.
- 10.2.11. F. Hoffmann-La Roche Ltd
- 10.2.12. Others